Zimmer Biomet makes a handful of executive changes under new CEO

From left: New Zimmer Biomet executive leadership team members Wilfred van Zuile, Mark Bezjack and Nitin Goyal.

Zimmer Biomet (NYSE: ZBH) + announced today that it made a number of updates to its executive leadership team.

The changes follow the recent appointment of Ivan Tornos to CEO after Bryan Hanson left for the corner office at 3M Healthcare.

Amid the changes, Zimmer Biomet named Wilfred van Zuilen group president, EMEA, and promoted Mark Bezjack to president of the Americas. Warsaw, Indiana-based Zimmer Biomet also added Chief Science, Technology and Innovation Officer Dr. Nitin Goyal to its executive leadership team. All appointments report directly to Tornos.

“The expansion of Zimmer Biomet’s executive leadership team coincides with our renewed focus on commercial execution and innovation to drive the Company forward,” said Tornos. “These appointments demonstrate the continued ev…

Read more
  • 0

Zimmer Biomet CEO leaves to take over another big medtech

Bryan Hanson will take over 3M’s soon-to-be independent healthcare business. [Image courtesy of 3M]Bryan Hanson has left the corner office of ortho tech giant Zimmer Biomet to become CEO of the soon-to-be-independent healthcare business at 3M, the companies announced today.

Hanson takes over 3M’s healthcare business on Sept. 1.

“I have a deep respect and admiration for what 3M has built in health care — strong brands, quality products, commercial excellence, and customer-driven innovation. I look forward to working with the team to more deeply understand and realize the potential of our business as we accelerate our path forward, and build on a legacy of trusted leadership and medical innovation,” Hanson said in a 3M news release.

Zimmer Biomet is promoting its COO Ivan Tornos to become its new CEO.

“I am grateful for Bryan’s leadership in transforming the company and am now looking forward to leading the team and accele…

Read more
  • 0

The 10 largest orthopedic device companies in the world

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker] Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year.

Stryker (NYSE: SYK) + and Zimmer Biomet (NYSE: ZBH) + both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic.

GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 billion this year. The question is whether companies can continue the momentum. Stryker and ZB are betting on innovation, building arrays of products and services around their surgical robotics systems and surgical planning and digital health tools.

During Zimmer Biomet’s second-quarter earnings call, CEO Bryan Hanson noted that ZB has 40 planned product …

Read more
  • 0

Zimmer Biomet beats The Street in Q2 — but it may not be enough

Zimmer Biomet (NYSE: ZBH) + today reported second-quarter results that beat Wall Street’s analysts’ expectations, again upping its guidance for the year.

“We’re pretty happy about the results we get to discuss today,” CEO Bryan Hanson told analysts. He added that the Warsaw, Indiana–based orthopedic device giant achieved its results in the face of significant macroeconomic challenges affecting the entire market.

The Q2 beat, however, may have not been enough for The Street. ZBH shares were down more than 5% to $130.71 apiece in morning trading. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was down slightly.

Truist analysts Richard Newitter, Samuel Brodovsky and Lin Zhang thought the Q2 results were good but “might not be enough on elevated ‘utilization’ expects.”

Zimmer Biomet earned…

Read more
  • 0

First clinical case performed with NeuroOne Evo sEEG, Zimmer Biomet Rosa One Brain

The Evo sEEG [Photo courtesy of NeuroOne]NeuroOne Medical Technologies (Nasdaq:NMTC) today announced the first clinical case performed with its Evo sEEG in robotic neurosurgery.

Dr. William Bingaman performed the procedure with the electrode — exclusively marketed by Zimmer Biomet — at Cleveland Clinic. It marks the first procedure to utilize NeuroOne’s Evo sEEG with Zimmer Biomet’s Rosa One Brain.

The Rosa One Brain, a robotic platform, assists surgeons in planning and performing complex, minimally invasive neurosurgical procedures.

Eden Prairie, Minnesota-based NeuroOne commercially launched its Evo sEEG electrode line in the U.S. earlier this month. The electrodes provide up to 30 days of recording, monitoring and stimulation of electrical signals at the subsurface level of the brain.

NeuroOne’s electrodes provide a similar function at the subsurface level of the brain compared to cortical electrodes. However, they util…

Read more
  • 0

Formus Labs wins clearance for AI-powered ortho surgery planning

Formus Labs today announced FDA clearance of its Formus Hip automated radiological image processing software for hip replacement pre-op planning.

The New Zealand–founded company described the clearance as the last hurdle it needed to overcome to start making Formus Hip widely available in the United States.

According to Formus Labs, its software saves time for orthopedic surgeons so that they can consistently preoperatively plan for every case. Formus’ software combines AI and computational biomechanics to provides highly accurate outputs from scan to plan in under an hour.

“Today is a huge milestone in our journey to bring cutting-edge, pre-op surgery planning tools to surgeons, not only to make their work easier and more efficient, but also has the potential to improve the outcomes for their patients,” Dr. Ju Zhang, founder and CEO of Formus Labs, said in a news release.

“FDA clearance serves as significant validation of the accuracy and r…

Read more
  • 0

NeuroOne launches Evo sEEG electrodes in the U.S.

The Evo sEEG [Photo courtesy of NeuroOne]NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it commercially launched its Evo sEEG electrode line in the U.S.

Zimmer Biomet holds exclusive worldwide distribution rights to the Evo Cortical and sEEG product lines. NeuroOne expects the line to utilize Zimmer Biomet’s Rosa One Brain robotic surgery platform for neurosurgical procedures. Zimmer paid $3.5 million to NeuroOne under the deal in August 2022. That came after an up-front payment of $2 million in 2020. NeuroOne began shipping commercial orders in the deal in November 2022.

“The commercial launch of the Evo sEEG platform represents one of the most impactful milestones in our company’s history,” said NeuroOne CEO Dave Rosa. “Paired with Zimmer Biomet’s ROSA One Brain robotic platform and broad distribution network, we believe the Company is well positioned in the market given the synergies that exist between our novel thin film ele…

Read more
  • 0

Zimmer Biomet’s profits were 16 times greater in Q1

Zimmer Biomet (NYSE: ZBH) + saw its stock rise today on Street-beating first-quarter results and raised guidance that analysts described as impressive. 

ZBH shares were up more than 3% to $143.68 by late morning. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up slightly.

News of the strong Q1 comes a day after Zimmer Biomet announced its latest acquisition — Ossis, a maker of personalized 3D-printed implants.

ZB’s results should add to the case that this could be a boom year for the orthopedic device market. The space is benefitting from a bounce-back of procedures as the COVID-19 situation normalizes.

BTIG analysts’ note had the headline, “Orthopedics is having its moment, and ZBH is benefiting.” Along with the backlog of patients, there are easy comps and multiple technologies that provide faster recovery, according to …

Read more
  • 0

Zimmer Biomet to acquire 3D-printed implant maker Ossis

Zimmer Biomet (NYSE: ZBH) +  announced today that it reached a definitive agreement to acquire Ossis, a maker of personalized 3D-printed implants.

Ossis also offers complex hip replacements, including second-time replacements and ones involving bone tumors and trauma.

The company boasts rapid design and production of personalized implants. This aligns with ZB’s commitment to providing personalized experiences, according to a news release.

“Combining Ossis’s more than 16 years of clinical experience and engineering expertise with Zimmer Biomet’s extensive network across Asia Pacific, Europe, the Middle East and Africa demonstrates our commitment to bring transformative med tech advancements to patients in need,” said Sang Yi, Zimmer Biomet Asia Pacific group president.

ZB entered into an agreement with Ossis in July 2021. The agreement made Ossis the company’s Asia Pacifi…

Read more
  • 0

The top orthopedic device news out of AAOS 2023

Stryker’s next-gen Mako total robotic knee surgery system and more AI integration for Zimmer Biomet’s ZBEdge surgical platform topped the news at this year’s AAOS 2023.

The American Academy of Orthopaedic Surgeons 2023 annual meeting drew top medical and medtech talent to Las Vegas from March 7–11.

Here is a roundup of major news coming out of the show:

Stryker launches Mako Total Knee 2.0 surgical robotics platform The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker]Stryker unveiled Mako Total Knee 2.0 at AAOS 2023. Informed by more than 500,000 procedures, Stryker said it designed the next-gen version of the robotic knee surgery system to provide an elevated user experience with customizable workflows and other key features. New features include a digital tensioner for assessing knee stability intraoperatively during total knee arthroplasty — without the need f…
Read more
  • 0

Zimmer Biomet unveils enhancements to ZBEdge platform

The Canary Medical orthopedic analytics module integrates with the Persona IQ Smart Knee. [Image from Zimmer Biomet’s website]Zimmer Biomet (NYSE:ZBH) today announced plans to unveil new enhancements to its ZBEdge Dynamic Intelligence platform.

Warsaw, Indiana-based Zimmer Biomet designed the platform to integrate its digital, robotic and implant technologies. It connects and collects objective data throughout the entire episode of care. The company aims for ZBEdge Dynamic Intelligence to transform data into insights and elevate the standard of care.

Zimmer Biomet plans to unveil enhancements this week at the American Academy of Orthopaedic Surgeons (AAOS) 2023 Annual Meeting in Las Vegas.

Enhancements include updates for the MyMobility platform, Rosa Knee, Persona IQ and more.

“Nearly two years following its introduction, ZBEdge Dynamic Intelligence continues to deliver innovations with breakthrough technologies designed to enable smarte…

Read more
  • 0

Could 2023 be a boom year for orthopedic devices?

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker]The orthopedic devices market is expected to reach nearly $50 billion this year as procedures bounce back from COVID-19, according to GlobalData.

GlobalData predicts the orthopedic surgical robotics space will be even hotter this year, growing 25.6% year-over-year to $984 million.

“Boosted by artificial intelligence (AI) and machine learning, new generations of orthopedic robots are expected to further improve clinical outcomes. Unlike the general surgery robotics market — which is dominated by only one company, Intuitive Surgical — all major orthopedic manufacturers are competing in the orthopedic robotics market,” Tina Deng, principal medical devices analyst at GlobalData, said in a news release posted Feb. 1.

In addition, Global Data noted that the pandemic has accelerated the shift of procedures to outpatient or ambulat…

Read more
  • 0